Seven RCTs (n=286), of which 4 were published as full reports and 3 as abstracts, were included.
Effect of noninvasive positive pressure ventilation on mortality (5 RCTs: 4 full reports and 1 abstract): the summary OR demonstrated a statistically-significant greater survival benefit in favour of the treatment, (OR 0.29, 95% CI: 0.15, 0.59); the test for heterogeneity was non significant.
Effect of noninvasive positive pressure ventilation on need for endotracheal intubation (5 RCTs: 3 full reports and 2 abstracts): the summary OR for treatment was 0.20 (95% CI: 0.11, 0.36); the test for heterogeneity was non significant.
Sensitivity analysis - influence of underlying disease: when 3 RCTs of patients with COPD and 2 trials of non-COPD patients were analysed separately, a statistically-significant effect was seen in favour of treatment for COPD patients (summary OR 0.12, 95% CI: 0.05, 0.29), whilst a non significant benefit was observed in non-COPD patients (summary OR 0.77, 95% CI: 0.23, 2.55).
Sensitivity analysis - influence of publication status of trials: the inclusio or exclusion of full reports or abstracts did not influence any of the above results.